言語を選択

HLA-A*0201 | B2M | TRI

お問い合わせ

市販薬剤に関する情報

英語名	研究コード	研究開発ステージ	会社	オリジナル製品名	最初に承認をした国	最初の適応症	最初に承認を受けた会社	承認された日付	適応症	臨床試験
Interferon beta (Toray/Daiichi Sankyo)	DL-8234	Approved		Feron	Japan	Hepatitis C; Astrocytoma; Glioblastoma; Hepatitis B; Medulloblastoma; Melanoma	null	1985-04-01	Medulloblastoma; Glioblastoma; Hepatitis B; Hepatitis C; Astrocytoma; Melanoma	詳細
Recombinant human interferon alfa-2b (Harbin Pharmaceutical Group Bioengineering)		Approved	Harbin Pharmaceutical Group Holding Co Ltd	里亚美, 利分能	Mainland China	Condylomata Acuminata; Varicella Zoster Virus Infection; Leukemia, Hairy Cell; Leukemia, Myelogenous, Chronic; Lymphoma, Non-Hodgkin; Multiple Myeloma; Hepatitis, Viral, Human	Harbin Pharmaceutical Group Pharmaceutical Co Ltd	1996-01-01	Leukemia, Myelogenous, Chronic; Leukemia, Hairy Cell; Varicella Zoster Virus Infection; Multiple Myeloma; Hepatitis, Viral, Human; Lymphoma, Non-Hodgkin; Condylomata Acuminata	詳細
Recombinant human interferon α2b biosimilar (Harbin High-Tech White Swan Pharmaceutical)		Approved	Harbin High-Tech Group Baitian'Er Pharmaceutical Co Ltd	Fu Li Sheng					Leukemia, Hairy Cell; Hepatitis; Multiple Myeloma; Leukemia, Myeloid, Chronic-Phase; Lymphoma, Non-Hodgkin; Herpes Zoster; Condylomata Acuminata	詳細
Anifrolumab	MDX-1333; MEDI-546	Approved	Medimmune Llc, Medarex	SAPHNELO	United States	Lupus Erythematosus, Systemic	Astrazeneca Ab	2021-07-30	Polymyositis; Hidradenitis; Dermatomyositis; Myositis; Atherosclerosis; Scleroderma, Systemic; Lupus Erythematosus, Cutaneous; Sjogren's Syndrome; Autoimmune Diseases; Lupus Nephritis; Lupus Erythematosus, Systemic; Cardiovascular Diseases; Hidradenitis Suppurativa; Vitiligo	詳細
Recombinant human interferon α2b biosimilar (Zhejiang Hansheng)		Approved	Zhejiang Hansheng Pharmaceutical Co Ltd Of Beisheng Pharma	莱福隆	Mainland China	Neoplasms; Virus Diseases	Zhejiang Hansheng Pharmaceutical Co Ltd Of Beisheng Pharma	1999-01-01	Neoplasms; Virus Diseases	詳細